Why Johnson Matthey plc is set to be a millionaire-maker stock

G A Chester discusses the huge potential of Footsie giant Johnson Matthey plc (LON:JMAT) and a smaller growth stock.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Speciality chemical and sustainable technologies giant Johnson Matthey (LSE: JMAT) today released results for its half year ended 30 September. It headlined the announcement: “Strong operational momentum continued and full-year outlook confirmed,” but the shares are trading a couple of percent lower at around 3,200p.

The company posted a 15% rise in reported revenue to £6.5bn, driven by higher platinum-group metals (PGM) prices and a £179m foreign exchange (FX) benefit. Excluding PGM and at constant FX rates, sales were up 5%.

A strong performance from the company’s Clean Air division (around two-thirds of group revenue) was led by double-digit growth of Heavy Duty Diesel catalysts in every region. And it saw growth in the Efficient Natural Resources and Health businesses. Only the relatively small New Markets division failed to contribute, with sales being little changed from the same period last year.

Technology leadership

With its technology leadership, Johnson Matthey’s Clean Air business is set to benefit from tighter legislation across the world, particularly in China and Europe. Add in its growing pipeline in Health and targeted investment in Efficient Natural Resources and there is a compelling proposition for investors.

Chief executive Robert MacLeod said today: “We are building a stronger platform from which we will achieve our goal of attractive returns to shareholders over the medium term: mid-to-high single-digit earnings per share growth, expanding return on invested capital to 20% and a progressive dividend.”

A current-year forecast price-to-earnings (P/E) ratio of 15.5 and a prospective dividend yield of 2.5% strike me as attractive for the medium-term growth outlook. But there’s also huge potential in the New Markets division, notably in the company’s development of the world’s first cobalt-free battery. This could be a major kicker — a game-changer even — for long-term earnings and dividend growth. As such, I rate the stock a ‘buy’.

Eyecatcher

Also in the industrial chemicals sector, FTSE SmallCap firm Zotefoams (LSE: ZTF) is a company that’s caught the eye this year, with its shares having risen by as much as 58%. The business rightly deserves investor attention, in my view. It uses a unique manufacturing process of environmentally friendly nitrogen expansion to produce a range of foams — including lightweight, high-performance and advanced insulation — which it sells into diverse markets worldwide.

A Q3 trading update earlier this month, in which management advised that full-year revenue is expected to be ahead of market expectation and profit at the top end of the range, is indicative of the strong demand for the Croydon-based firm’s products and its increasing penetration of international markets.

At 375p, the shares have eased back from their post-trading-update high of near to 400p. The current-year forecast P/E is still relatively high at 24 but it falls to 21 next year and I see the long-term growth prospects as highly appealing. I also expect the current modest dividend (the yield is 1.6%) to advance strongly with earnings growth in the coming years and this is another stock I also rate a ‘buy’.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. TThe Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Businesswoman calculating finances in an office
Investing Articles

As earnings growth boosts the Imperial Brands share price, is it a top FTSE 100 dividend choice?

The Imperial Brands share price has come storming back as investors piled in for the big dividends. What's next, after…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
US Stock

Warren Buffett just bought and sold these stocks. Here’s why I don’t agree

Jon Smith takes a look at the recent regulatory filing for Berkshire Hathaway and Warren Buffett and comments on recent…

Read more »

US Stock

My favourite US growth stock’s up 33% this year. I think it’s just getting started

Edward Sheldon's taken a large position in this well-known S&P 500 growth stock. And so far, it’s working very well…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

The Diploma share price falls 7% as revenues and profits keep growing. Time to buy?

As Diploma continues its impressive growth, its share price is faltering. Stephen Wright takes a closer look at one of…

Read more »

Growth Shares

Directors at this FTSE 100 company just bought over £2m worth of shares

Shares in this FTSE 100 pharma company have plummeted in recent months. And company insiders are betting on a potential…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Down 24%! As the Glencore share price falls like snow, is it finally time to let it go?

Harvey Jones thought the Glencore share price was in bargain territory when he bought the FTSE 100 commodity giant last…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

591 shares in this FTSE 100 high-yield gem could make me £14,873 a year in passive income over time!

A big passive income can be generated from much smaller investments earlier in life, especially if the dividend returns are…

Read more »

Investing Articles

With a P/E ratio of 5.6, is the BP share price an unmissable bargain?

Harvey Jones took advantage of the falling BP share price in September, thinking it was too cheap to ignore. It…

Read more »